Testing Experimental Medication in Healthy Subjects
common.study.values.description
“A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants”
The purpose of this study is to evaluate the serum concentration of guselkumab after administration using three different devices in healthy participants.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Guselkumab
Guselkumab will be administered subcutaneously.
participant.views.study.view.additional
participant.views.study.view.scientific-title
An Open-label, Randomized, Parallel-group Study to Assess the Pharmacokinetic Bioequivalence of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants
common.study.values.clinical-trial-id
NCT04147338
participant.views.study.view.id
bkREXa
